Patents-Review.com
ClassID:

114921 ⎘

C12Y201/03003 - CPC Classification

Classification description:

Transferases transferring one-carbon groups (2.1); Carboxy- and carbamoyltransferases (2.1.3) Ornithine carbamoyltransferase (2.1.3.3)

Recent Application in this class:
#1
20260078356
2026-03-19

COMPOSITIONS AND METHODS FOR TREATING ORNITHINE TRANSCARBAMYLASE DEFICIENCY

 #2
20260049299
2026-02-19

METHODS FOR PURIFICATION OF MESSENGER RNA

 #3
20250339480
2025-11-06

ADENO-ASSOCIATED VIRUS VIRION FOR TREATING ORNITHINE TRANSCARBAMYLASE DEFICIENCY

 #4
20250333751
2025-10-30

MICROORGANISM WITH L-ORNITHINE PRODUCTION CAPABILITY AND METHOD FOR PRODUCING L-ORNITHINE USING SAME

 #5
20250312422
2025-10-09

COMPOSITIONS AND METHODS FOR FACILITATING DELIVERY OF SYNTHETIC NUCLEIC ACIDS TO CELLS

 #6
20250277226
2025-09-04

IMPROVED BIOTECHNOLOGICAL METHOD FOR PRODUCING GUANIDINO ACETIC ACID (GAA) BY INACTIVATION OF AN AMINO ACID EXPORTER

 #7
20250207161
2025-06-26

L-AMINO ACID-PRODUCING MICROORGANISM HAVING WEAKENED CARBAMOYL PHOSPHATE SYNTHASE ACTIVITY, AND L-AMINO ACID PRODUCTION METHOD USING SAME

 #8
20250171790
2025-05-29

METHOD FOR THE FERMENTATIVE PRODUCTION OF GUANIDINOACETIC ACID

 #9
20250163481
2025-05-22

IMPROVED BIOTECHNOLOGICAL METHOD FOR PRODUCING GUANIDINO ACETIC ACID (GAA) BY USING NADH-DEPENDENT DEHYDROGENASES

 #10
20250161493
2025-05-22

COMPOSITIONS AND METHODS FOR IN VIVO NUCLEASE-MEDIATED TREATMENT OF ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY

 #11
20250161221
2025-05-22

Lyophilized Pharmaceutical Compositions Comprising A Lipid Nanoparticle

 #12
20250152739
2025-05-15

COMPOSITION AND METHODS FOR TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY

 #13
20250136953
2025-05-01

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY

 #14
20240408020
2024-12-12

Lyophilized Pharmaceutical Compositions Comprising a Lipid Nanoparticle

 #15
20240398720
2024-12-05

CATIONIC POLYMERS

 #16
20240316130
2024-09-26

COMPOSITION AND METHODS INCLUDING RECOMBINANT VIRUSES MODULATING ARGININE BIOSYNTHESIS

 #17
20240247239
2024-07-25

POLYNUCLEOTIDES ENCODING ORNITHINE TRANSCARBAMYLASE FOR THE TREATMENT OF UREA CYCLE DISORDERS

 #18
20240189449
2024-06-13

LIPID NANOPARTICLES AND POLYNUCLEOTIDES ENCODING ORNITHINE TRANSCARBAMYLASE FOR THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY

 #19
20240189446
2024-06-13

COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS

 #20
20240041789
2024-02-08

Process of Preparing mRNA-Loaded Lipid Nanoparticles

 #21
20240002815
2024-01-04

COMPOSITIONS AND METHODS FOR TREATING ORNITHINE TRANSCARBAMYLASE DEFICIENCY

 #22
20240000969
2024-01-04

COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS

 #23
20230416700
2023-12-28

COMPOSITIONS USEFUL IN TREATMENT OF ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY

 #24
20230104091
2023-04-06

COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC LIVER DISORDERS

 #25
20230065040
2023-03-02

SUBCUTANEOUS DELIVERY OF MESSENGER RNA

 #26
20230001021
2023-01-05

ORNITHINE TRANSCARBAMYLASE (OTC) CONSTRUCTS AND METHODS OF USING THE SAME

 #27
20220202718
2022-06-30

Cleavable lipids

 #28
20220073944
2022-03-10

MULTIMERIC CODING NUCLEIC ACID AND USES THEREOF

 #29
20220072152
2022-03-10

Composition and methods for treatment of ornithine transcarbamylase deficiency

 #30
20220054602
2022-02-24

mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES

 #31
20220025399
2022-01-27

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

 #32
20210284974
2021-09-16

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY

 #33
20210230648
2021-07-29

Arginine supplementation to improve efficiency in gas fermenting acetogens

 #34
20210205421
2021-07-08

Messenger RNA therapy for the treatment of ornithine transcarbamylase deficiency

 #35
20210180041
2021-06-17

Methods For Purification of Messenger RNA

 #36
20210123041
2021-04-29

Methods for purification of messenger RNA

 #37
20210113483
2021-04-22

Cationic polymers

 #38
20210054347
2021-02-25

Microorganism for producing ornithine and process for producing ornithine using them

 #39
20210052706
2021-02-25

Compositions and methods for facilitating delivery of synthetic nucleic acids to cells

 #40
20200377866
2020-12-03

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

 #41
20200308557
2020-10-01

FUSION PROTEINS

 #42
20200308556
2020-10-01

Ornithine transcarbamylase coding polyribonucleotides and formulations thereof

 #43
20200299652
2020-09-24

Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders

 #44
20200237671
2020-07-30

Cleavable lipids

 #45
20200190486
2020-06-18

Microorganisms for producing putrescine or ornithine and process for producing putrescine or ornithine using them

 #46
20200181584
2020-06-11

Compositions and methods for treating ornithine transcarbamylase deficiency

 #47
20200172923
2020-06-04

Multimeric coding nucleic acid and uses thereof

 #48
20200016278
2020-01-16

Stable gene transfer to proliferating cells

 #49
20190365926
2019-12-05

Polynucleotides and vectors for the expression of transgenes

 #50
20190314284
2019-10-17

Cleavable lipids

 #51
20190298755
2019-10-03

Subcutaneous delivery of messenger RNA

 #52
20190292563
2019-09-26

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

 #53
20190249191
2019-08-15

Multimeric coding nucleic acid and uses thereof

 #54
20190192688
2019-06-27

Composition and methods for treatment of ornithine transcarbamylase deficiency

 #55
20190136274
2019-05-09

Microorganisms having putrescine productivity and process for producing putrescine using the same

 #56
20190071651
2019-03-07

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

 #57
20190017068
2019-01-17

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

 #58
20180251755
2018-09-06

Methods for purification of messenger RNA

 #59
20180251754
2018-09-06

Methods for purification of messenger RNA

 #60
20180236047
2018-08-23

MRNA for use in treatment of human genetic diseases

 #61
20180187222
2018-07-05

Microorganisms for producing putrescine or ornithine and process for producing putrescine or ornithine using them

 #62
20180169020
2018-06-21

Cleavable lipids

 #63
20180153822
2018-06-07

Process of Preparing mRNA-Loaded Lipid Nanoparticles

 #64
20180135030
2018-05-17

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

 #65
20180105850
2018-04-19

L-ornithine production in eukaryotic cells

 #66
20180103619
2018-04-19

Disease model pig exhibiting stable phenotype, and production method thereof

 #67
20180051262
2018-02-22

Messenger UNA molecules and uses thereof

 #68
20180008680
2018-01-11

Messenger RNA therapy for the treatment of ornithine transcarbamylase deficiency

 #69
20180008543
2018-01-11

Cleavable Lipids

 #70
20170314041
2017-11-02

Multimeric coding nucleic acid and uses thereof

 #71
20170306354
2017-10-26

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

 #72
20170216456
2017-08-03

Stable Gene Transfer to Proliferating Cells

 #73
20170159083
2017-06-08

Arginine supplementation to improve efficiency in gas fermenting acetogens

 #74
20170088858
2017-03-30

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

 #75
20170051259
2017-02-23

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

 #76
20170021037
2017-01-26

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

 #77
20170002386
2017-01-05

Microorganisms having putrescine productivity and process for producing putrescine using the same

 #78
20160201088
2016-07-14

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

 #79
20160130567
2016-05-12

MESSENGER UNA MOLECULES AND USES THEREOF

 #80
20160101160
2016-04-14

mRNA for use in treatment of human genetic diseases

 #81
20150176027
2015-06-25

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

 #82
20150139953
2015-05-21

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

 #83
20150004217
2015-01-01

mRNA for use in treatment of human genetic diseases

 #84
20140288160
2014-09-25

Cleavable lipids

 #85
20140004577
2014-01-02

Microorganisms for producing putrescine and method for producing putrescine using same

 #86
20130344545
2013-12-26

Microorganisms having improved ornithine-producing ability and method for producing ornithine using the same

 #87
20120142756
2012-06-07

mRNA for use in treatment of human genetic diseases

 #88
20090227030
2009-09-10

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

 #89
20080075740
2008-03-27

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

 #90
20080075737
2008-03-27

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor